Dislocation of Rab13 and vasodilator-stimulated phosphoprotein...

Collect this paper and discover other ones on Labmeeting. Learn more.
- Hide Abstract
Crohn's disease is associated with increased permeability of the intestine even in quiescent patients. Increased intestinal permeability may cause dysregulated immunological responses in the intestinal mucosa that leads to chronic intestinal inflammation. Tight junction proteins contribute to intestinal permeability, and functional abnormality and dislocation of such proteins may cause increased intestinal permeability. We studied the expression of tight junction proteins Rab13, vasodilator-stimulated phosphoprotein (VASP), zonula occludin-1 (ZO-1), and F-actin in the intestinal epithelium of patients with inactive inflammatory bowel disease. Surgical samples were obtained from 10 controls (without inflammatory bowel disease), 10 patients with Crohn's disease and 7 patients with ulcerative colitis. F-actin was visualized with fluorescent phalloidin. Tight junction proteins were visualized by an immunofluorescence method. Rab13, VASP, and ZO-1 were found in apical tight junctions in normal epithelium but were dislocated to the basolateral position in patients with inactive Crohn's disease, whereas the structure of F-actin was maintained in inactive mucosa. In patients with ulcerative colitis, these tight junction proteins were not dislocated. Latent dislocation of tight junction proteins in the inactive mucosa of patients with Crohn's disease may permit the invasion of gut antigens to initiate and perpetuate altered immune response.
International journal of molecular medicine 24(6):829-35, 2009 DecWho cited this? | PubMed ID: 19885626 | Fulltext


+ Click Here for Related Papers


Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!